Company Overview of Ceres Ventures, Inc., Prior to Reverse Merger with BluFlow Technologies, Inc.
As of December 29, 2011, Ceres Ventures, Inc. was acquired by BluFlow Technologies, Inc., in a reverse merger transaction. Ceres Ventures, Inc. engages in identification, acquisition, development, and commercialization of anti-cancer biopharmaceutical compounds and compounds for treating hematologic disorders. Its products include D11B, an anti-cancer compound, for the treatment of glioblastoma. The company was formerly known as PhytoMedical Technologies Inc. and changed its name to Ceres Ventures, Inc. in November 2011. Ceres Ventures, Inc. was founded in 1986 and is based in Princeton, New Jersey.
100 Overlook Drive
Princeton, NJ 08540
Founded in 1986
Key Executives for Ceres Ventures, Inc., Prior to Reverse Merger with BluFlow Technologies, Inc.
Ceres Ventures, Inc., Prior to Reverse Merger with BluFlow Technologies, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|MaxCyte, Inc.||United States|
|ProteinTech Group Inc.||United States|
|Laser Isotope Enrichment Laboratory||United States|
|Ophtalox, Inc.||United States|
|Multispan, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Ceres Ventures, Inc., Prior to Reverse Merger with BluFlow Technologies, Inc., please visit www.phytomedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.